Go back to News
NEWS
GA_P advises Vista Equity Partners on €2.425m acquisition of Duck Creek
10 of January, 2023
GA_P has advised investment fund Vista Equity Partners on the Spanish leg of the acquisition of Duck Creek Technologies (NASDAQ: DCT) to delist it from the stock exchange.
Vista Equity Partners has reached an agreement with technology company Duck Creek Technologies to acquire it for a total of $2.6 billion (€2.425 billion) in cash. The deal is expected to close in the second quarter of 2023, subject to the satisfaction of certain conditions customary in such transactions, after which the entity will be delisted.
Duck Creek specialises in providing customer management software products to insurance companies and broker-dealers.
Vista Equity Partners is a leading global investment fund investing in enterprise software, data and technology companies.
They advised on the transaction: Alex Pujol, partner of Commercial, Andrea Esbrí, senior associate of Commercial, Mònica Martells, associate of Commercial, and Anna Viladás and Paula Ruiz Cotorro from Industrial Property, Intellectual Property and Technology.
Vista Equity Partners has reached an agreement with technology company Duck Creek Technologies to acquire it for a total of $2.6 billion (€2.425 billion) in cash. The deal is expected to close in the second quarter of 2023, subject to the satisfaction of certain conditions customary in such transactions, after which the entity will be delisted.
Duck Creek specialises in providing customer management software products to insurance companies and broker-dealers.
Vista Equity Partners is a leading global investment fund investing in enterprise software, data and technology companies.
They advised on the transaction: Alex Pujol, partner of Commercial, Andrea Esbrí, senior associate of Commercial, Mònica Martells, associate of Commercial, and Anna Viladás and Paula Ruiz Cotorro from Industrial Property, Intellectual Property and Technology.
Press contact
Director of Business Development, Marketing and Communications
Director of Business Development, Marketing and Communications
More information about
Gómez-Acebo & Pombo
15 Jul, 2025 
PUBLICATION
¡NEW!
Absolute prohibitions on pharmacy advertising are contrary to EU law
In its judgment of 19 June 2025 (European Commission v Republic of Poland, C‑200/24, ECLI:EU:C:2025:459), the Court of Justice has held that the introduction by national legislation of a total prohibition on advertising for pharmacies infringes European Union law.
¡NEW! 
PUBLICATION
¡NEW!
The use of personal data to train artificial intelligence systems
The judgment of the Regional High Court (Oberlandesgericht) of Cologne of 23 May 2025 (15 UKl 2/25), in which the German court rejects the application for interim relief prohibiting the defendant from processing personal data published by consumers on Facebook and Instagram for the development and improvement of artificial intelligence systems, is analysed.
¡NEW!
PUBLICATION
09 Jul, 2025
Once again on the obligations assumed by the signers of a "strong" comfort letter
09 Jul, 2025
PUBLICATION
02 Jul, 2025
Pharma & Healthcare No. 44
The newsletter covers the main developments in Pharma & Healthcare legislation and case law.
02 Jul, 2025
PUBLICATION
19 Jun, 2025
Company resolutions reached with invalid votes
Although Article 204(3)(d) places them on the same level, the erroneous counting of votes and the counting of invalid votes are very different, given that the latter requires judicial balancing.
19 Jun, 2025
PUBLICATION
13 Jun, 2025
Limits of the Unified Patent Court's long arm with regard to Spain (IV): the recognition and enforcement of court decisions
The Unified Patent Court has jurisdiction, in certain cases and within the limits set by the Brussels Ia Regulation and the Lugano Convention, to hear actions relating to classic European patents validated in States that are not party to the Agreement on a Unified Patent Court. Such decisions may be recognised and enforced in those other countries, but there are cases in which such recognition and enforcement will not be appropriate.
13 Jun, 2025
PUBLICATION
12 Jun, 2025
Limits of the Unified Patent Court's long arm with regard to Spain (III): applicable law
The Unified Patent Court has jurisdiction, in certain cases and within the limits laid down in the Brussels Ia Regulation and the Lugano Convention, to hear actions relating to classic European patents validated in States that are not contracting parties to the Agreement on a Unified Patent Court. However, this does not mean that, when hearing such actions, the Court may apply the same rules as if the actions related to a unitary patent.
12 Jun, 2025
PUBLICATION
11 Jun, 2025
Limits of the Unified Patent Court's long arm with regard to Spain (II): the controversial judgment of the Court of Justice in the BSH/Electrolux case
This document sets out and criticises the doctrine established by the CJEU in its Judgment of 25 February 2025, C-339/22, BSH/Electrolux, ECLI:EU:C:2025:108. Although the dispute underlying the judgment was not brought before the UPC, the interpretation of the CJEU in the BSH/Electrolux judgment is equally applicable, since said court is equivalent to the national courts of the contracting states party to the UPC Agreement.
11 Jun, 2025
PUBLICATION
10 Jun, 2025
Limits of the Unified Patent Court's long arm with regard to Spain (I): international jurisdiction
Ever since coming into operation, there has been a tendency on the part of the Unified Patent Court to extend its jurisdiction to include patents that produce effects in States that are not party to the Agreement on a Unified Patent Court (the ‘UPC Agreement’ or ‘Agreement’), as is the case of the Kingdom of Spain. This phenomenon is known in specialised circles as the court's ‘long arm’. However, although in certain cases the Unified Patent Court (the ‘UPC’ or ‘Court’) does indeed have such jurisdiction, this is only possible within strict limits, limits that do not seem to be taken into consideration in a consistent manner.
10 Jun, 2025